Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ga-68 PSMA-11 PET in Prostate Cancer
NCT02611882Phase 2Completed
- Start
- Dec 2015
- Primary completion
- Oct 2016
- Modality
- Peptide-Drug Conjugates
- Countries
- 1
01
Overview
A Phase 2 trial of gallium ga-68 gozetotide in prostate cancer (PCa). Started Dec 2015; status: completed.
02
Drugs
gallium ga-68 gozetotide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT02611882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02611882.